Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet therapy for primary prevention of cardiovascular disease in stable COPD
ISRCTN43245574Phase 2Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of aspirin and ticagrelor in cardiac morbidity (5 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Started Sep 2015; status: completed.
02
Drugs
aspirinticagrelor
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on ISRCTN43245574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN43245574.